Benjamin A Teply Selected Research

Benjamin A Teply Research Topics

Disease

23	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 04/2006
16	Neoplasms (Cancer) 03/2024 - 04/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 01/2014
2	Circulating Neoplastic Cells 11/2021 - 10/2016
2	Neoplasm Metastasis (Metastasis) 05/2021 - 01/2019
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Cancer Pain 01/2023
1	Exanthema (Rash) 12/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2021
1	Bullous Pemphigoid (Pemphigoid) 12/2021
1	Blister (Bulla) 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Proteinuria 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Cardiotoxicity 01/2020
1	Microsatellite Instability 08/2017
1	Disease Progression 01/2014
1	Hemorrhagic Cystitis 09/2012
1	Urogenital Neoplasms 09/2012
1	Body Weight (Weight, Body) 04/2006
1	Hypoglycemia (Reactive Hypoglycemia) 03/2006

Drug/Important Bio-Agent (IBA)

6	AndrogensIBA 10/2023 - 01/2016
4	Testosterone (Sustanon)FDA Link 11/2023 - 01/2017
3	Androgen Receptors (Androgen Receptor)IBA 11/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2021
3	Neuropilin-2IBA 11/2023 - 05/2021
3	abirateroneIBA 01/2021 - 01/2018
3	Nucleotide AptamersIBA 01/2012 - 04/2006
3	APTIBA 02/2008 - 04/2006
3	antineoplaston A10 (A 10)IBA 02/2008 - 04/2006
3	AntigensIBA 02/2008 - 04/2006
2	LigandsIBA 11/2023 - 01/2012
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2023 - 10/2016
2	PlatinumIBA 01/2023 - 08/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 08/2017
2	NivolumabIBA 04/2022 - 12/2021
2	Immune Checkpoint InhibitorsIBA 04/2022 - 08/2017
2	Prednisone (Sone)FDA LinkGeneric 12/2021 - 01/2019
2	enzalutamideIBA 01/2021 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2014
2	Docetaxel (Taxotere)FDA Link 11/2020 - 04/2006
1	EnzymesIBA 11/2023
1	Vascular Endothelial Growth Factor CIBA 11/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	pembrolizumabIBA 04/2022
1	Proton Pump InhibitorsIBA 04/2022
1	CytokinesIBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 12/2021
1	Circulating Tumor DNAIBA 11/2021
1	taxaneIBA 05/2021
1	Gemcitabine FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2020
1	Phosphodiesterase 5 InhibitorsIBA 11/2020
1	Sildenafil Citrate (Viagra)FDA Link 11/2020
1	Androgen Antagonists (Antiandrogens)IBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2017
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 02/2008
1	poly(lactic-glycolic acid)-poly(ethyleneglycol) copolymerIBA 04/2006
1	Insulin (Novolin)FDA Link 03/2006
1	Polyglactin 910IBA 03/2006
1	Ferrosoferric Oxide (Magnetite)FDA Link 03/2006

Therapy/Procedure

19	Therapeutics 03/2024 - 01/2012
10	Castration 10/2023 - 01/2016
10	Drug Therapy (Chemotherapy) 09/2023 - 04/2006
3	Immunotherapy 01/2023 - 08/2017
2	Radiotherapy 12/2021 - 09/2012
1	Combination Drug Therapy (Combination Chemotherapy) 01/2023
1	Injections 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Neoadjuvant Therapy 01/2014
1	Semiconductor Lasers 09/2012